Institute of Medical Radiation and Cell Research struction of naive nuclei, whereas mitochondria purified Bayerische Julius-Maximilians-Universitä t from Bcl-2 overexpressing cells do not (Zamzami et al., D097078 Wurzburg 1996) . Interestingly, chemical inducers of mitochondrial Federal Republic of Germany megapore opening (permeability transition) can induce normal mitochondria derived from healthy cells to liberate factors that result in apoptosis-like destruction of Summary nuclei (Zamzami et al., 1996) . Moreover, release of cytochrome C from mitochondria occurs during apoptosis A green fluorescent protein (GFP)-Raf-1 fusion protein and can promote activation of proteases of the interleuwas used to show that Bcl-2 can target this kinase to kin-1␤-converting enzyme (ICE) family (Liu et al., 1996) . mitochondria. Active Raf-1 fused with targeting seOverexpression of Bcl-2 has also been reported to prequences from an outer mitochondrial membrane provent the dumping of mitochondrial Ca 2ϩ into the cytosol tein protected cells from apoptosis and resulted in of cells treated with uncouplers of oxidative phosphoryphosphorylation of BAD, a proapoptotic Bcl-2 homolation (Baffy et al., 1993) , a known stimulus for inducing log. Plasma membrane-targeted Raf-1 did not protect permeability transition in mitochondria (Bernardi et al. , from apoptosis and resulted in phosphorylation of 1994). Finally, mutant versions of Bcl-2 lacking their ERK-1 and ERK-2. Untargeted active Raf-1 improved C-terminal TM domain inefficiently associate with mitoBcl-2-mediated resistance to apoptosis, whereas a chondria and are impaired in their ability to prevent cell kinase-inactive Raf-1 mutant abrogated apoptosis death (Tanaka et al., 1993; Nguyen et al., 1994) , whereas suppression by Bcl-2. Bcl-2 can therefore target Raf-1 substitution of a TM domain from the yeast outer-mitoto mitochondrial membranes, allowing this kinase to chondrial membrane protein Mas70p restores targeting phosphorylate BAD or possibly other protein subto mitochondria and returns full antiapoptotic function strates involved in apoptosis regulation. . Bcl-2 family proteins contain up to four conserved Introduction domains: BH1, BH2, BH3, and BH4. All antiapoptotic members of the Bcl-2 protein family contain the BH4 The Bcl-2 family of proteins consists of both inhibitors domain (Zha et al., 1996) , which is typically located and promoters of programmed cell death and apoptosis.
near the N-terminus of these proteins and corresponds Many of these proteins can interact with each other to the first amphipathic ␣ helix in the crystal structure through a complex network of homo-and heterodimers of the Bcl-X L protein, an antiapoptotic homolog of Bcl-2 Sedlak et al., 1995) . The relative ratios (Muchmore et al., 1996) . In contrast, the proapoptotic of pro-and antiapoptotic Bcl-2 family proteins determembers of the Bcl-2 family lack BH4, with the excepmine the ultimate sensitivity or resistance of cells to a tion of Bcl-X S . Deletion mutants of Bcl-2 lacking the wide variety of apoptotic signals (Oltvai and Korsmeyer, BH4 domain exhibit either loss of function or dominant-1994). The precise biochemical mechanisms by which inhibitory activity, paradoxically promoting apoptosis Bcl-2 family proteins exert their influence on cell life and (Borner et al., 1994; Hanada et al., 1995; Hunter et al., death, however, remain far from clear, though several 1996) , thus indicating the functional significance of the theories have been advanced, including regulation of BH4 domain. BH4 is not, however, required for binding organellar Ca 2ϩ homeostasis, reactive oxygen species to either Bax or wild-type Bcl-2 protein (Hanada et al., production, protein transport, cysteine protease activa-1995), suggesting that it plays a role in some other astion, and mitochondrial permeability transition (Baffy et pect of Bcl-2 function. al., 1993; Kane et al., 1993; Hockenbery et al., 1993;  In addition to dimerizing with other homologous pro- Krajewski et al., 1993; Ryan et al., 1994; Boulakia et al., teins, the Bcl-2 protein has been reported to associate 1996; Zamzami et al., 1996) .
with several other nonhomologous proteins, including Bcl-2 and most of its homologs contain hydrophobic the protein kinase Raf-1 ; Blastretches of amino acids near their C-termini (transmemgosklonny et al., 1996) . Raf-1 is best known for the role brane [TM] domains) that allow for their insertion into it plays in growth factor receptor-mediated signal transintracellular membranes. Though varying among differduction pathways involving p21 ras family proteins loent cell types and particular members of the Bcl-2 family, cated at the plasma membrane (Daum et al., 1994) . When in general, a large proportion of these protein molecules Ras assumes an active conformation through binding are associated with the outer mitochondrial membrane of GTP, a subpopulation of the Raf-1 protein molecules Gonzá lez-Garcia et al., 1994;  in cells translocates from the cytosol to the plasma Yang et al., 1995) . Several observations suggest an immembrane, via interaction with p21 ras (Hall, 1994) . The portant role for mitochondria in the control of apoptosis.
region on Raf-1 that binds to Ras corresponds to a negative regulatory domain located in approximately the For example, removal of mitochondria from cytosolic first third of the N-terminal length of the kinase (residues 51-149), upstream of the catalytic domain (residues 330-627) (Zhang et al., 1993) . This retargeting of Raf-1 to the plasma membrane both serves as a mechanism for locally activating this kinase and also probably helps to bring Raf-1 into contact with relevant physiological substrates (Stokoe et al., 1994; Leevers et al., 1994) . We provide evidence here that the Bcl-2 protein can target Raf-1 to mitochondria, through an interaction that depends on the BH4 domain in Bcl-2 and the catalytic domain in Raf-1, thus promoting resistance to apoptosis and altering the substrate preferences of Raf-1 in cells.
Results

Raf-1 Interaction with Bcl-2 Depends on BH4 Domain
We examined whether removal of the BH4 domain (residues 11-33) from Bcl-2 abolished its ability to interact with Raf-1 by using three approaches: first, binding of in vitro translated 35 S-labeled Bcl-2 or Bcl-2(⌬BH4) proteins to GST-Raf-1 fusion protein; second, yeast two-hybrid assays; and third, coimmunoprecipitation experiments where Bcl-2 and Bcl-2(⌬BH4) proteins were coexpressed with Raf-1 in Sf9 insect cells infected with recombinant baculoviruses ( Figures 1A-1C , respectively). All three of these approaches demonstrated a BH4 dependence for the interaction of Bcl-2 with Raf-1 and confirmed previous studies showing that the catalytic domain of Raf-1 is necessary and sufficient for this interaction . The proapoptotic protein Bcl-XS, which contains BH4 but lacks the BH1 and BH2 domains found in most other Bcl-2 family proteins, also can associate with Raf-1, whereas Bax (which lacks BH4) does not. To explore further the interaction of Bcl-2 and Raf-1, Domain. experiments were performed in 293 epithelial cells. If
Bcl-2 Targets Raf-1 to Mitochondria in a BH4-Dependent Manner in Mammalian Cells
Bcl-2 and Raf-1 associate in intact cells, we reasoned (center) proteins ‫5ف(‬ g) were immobilized on glutathionethat Bcl-2 should target a portion of the Raf-1 molecules Sepharose ‫02ف(‬ l) and then incubated with in vitro translated (IVT) from the cytosol to the same membranous locations 1(Cat) and wild-type Bcl-2 was concentrated in punctate foci in the cytosol, suggestive of association with mito-TM domain should target Raf-1 to the outer mitochondrial membrane without the assistance of Bcl-2. In addichondria or other organelles (Figure 2c ). Two-color analysis using a rhodamine-like dye that is specifically imtion, Mas70p TM-Raf-1 fusion constructs were prepared in which lysine 375 in Raf-1, which is critical for ATP ported into mitochondria (MitoTracker) confirmed that a large portion of the GFP-Raf-1 protein molecules were binding, was mutated, thereby producing a protein without kinase activity. Such kinase-inactive mutants of associated with mitochondria (Figures 2d-2f ). In contrast, when the GFP protein was expressed in 293 cells Raf-1 can often function as dominant inhibitors of the endogenous wild-type kinase (Kolch et al., 1991) . To without appended Raf-1 sequences, only a diffuse, mostly cytosolic staining was found; it failed to colocalavoid complications due to the association of Raf-1 with Ras-family proteins, both the kinase active and inactive ize with mitochondria, regardless of whether the cells coexpressed Bcl-2 or not (data not shown). Thus, Bcl-2 Mas70p-Raf-1 fusion proteins were expressed without the N-terminal portions of Raf-1 (residues 26-303) which did not cause nonspecific adsorption of GFP to mitochondria. Moreover, immunoblot analysis of the tranmediate binding to Ras (hereinafter referred to as M-Raf-1 and M-Raf-1(K375W)). As an additional control, siently transfected 293 cells confirmed production of comparable amounts of the wild-type and ⌬BH4 mutant the same Raf-1(⌬26-303) protein lacking the Ras-binding domain was fused with the CAAX box-containing Bcl-2 proteins (data not shown), indicating that the failure of GFP-Raf-1(Cat) to associate with mitochondria C-terminus of K-Ras, which targets Raf-1 specifically to the plasma membrane (Stokoe et al., 1994 ; Leevers et when coexpressed with Bcl-2(⌬BH4) could not be explained by inadequate production of this mutant protein.
al., 1994). These Raf-1 fusion proteins were stably expressed in 32D.3, a hemopoietic cell that is dependent on interleuTargeting Raf-1 to Mitochondria Enhances Its Antiapoptotic Activity kin-3 (IL-3) for its growth and survival. Immunoblot analysis of lysates prepared from these cells confirmed the The data presented above revealed that Bcl-2 can target Raf-1 to mitochondria but left unanswered the question production of the expected ‫54ف‬ kDa M-Raf-1, M-Raf-1(K375W), and Raf-1-CAAX proteins ( Figure 3A , lanes of the significance of this event for regulation of apoptosis. To address this issue, expression plasmids were 3-5). Targeting of the M-Raf-1 ( Figure 3B ) and M-Raf-1(K375W) (data not shown) proteins to mitochondria was constructed that produce Raf-1 fused with the TM domain of the yeast outer mitochondrial membrane protein verified by subcellular fractionation methods ( Figure 3B ), in which cytosolic (C), light membrane (LM), and heavy Mas70p (Hase et al., 1984) , with the idea that the Mas70p ure 3B). In contrast, the endogenous p72-Raf-1 wildtype protein was located mostly in the cytosolic fraction. The kinetics of cell death were explored in cultures studies where confirmed by flow cytometric DNA conof these 32D.3 cells expressing the M-Raf-1 and M-Raftent analysis propidium iodide-stained cells (data not 1(K375W) proteins when deprived of IL-3. When comshown), where the proportion of cells with subdipolid pared with 32D.3-Neo cells that received only the parenamounts of DNA, indicative of apoptosis, was detertal plasmid as a control, 32D.3 cells expressing the mined. This DNA content analysis also showed that de-M-Raf-1 protein exhibited a delay in cell death comparaspite their prolonged survival in IL-3-deficient medium, ble to that seen in transfected 32D.3 cells overexpressneither 32D.3-Bcl-2 nor 32D.3-M-Raf-1 cells continued ing Bcl-2 ( Figure 4A ). In contrast, 32D.3 cells expressing to cycle in the absence of IL-3, and the preponderance the M-Raf-1(K375W) protein experienced accelerated of these cells arrested in G0/G1-phase when deprived cell death, compared with the 32D.3-Neo control cells, of lymphokines. Taken together, therefore, these data when deprived of IL-3 ( Figure 4A ). 32D.3 cells expressing are consistent with the hypothesis that targeting active the Raf-1-CAAX protein, as well as the same cells exRaf-1 kinase to mitochondrial membranes can specifipressing Raf-1(Cat) protein lacking either a CAAX box cally enhance cellular resistance to apoptosis, whereas or the TM domain of Mas70p data interfering with action of endogenous Raf-1 at mitochonnot shown), displayed cell death kinetics comparable dria has the opposite effect. to those of the control transfectants ( Figure 4A ). The viability of all transfectants when cultured with IL-3 was Ն95% during the first 3 days of the experiment, but
The M-Raf-1 and M-Raf-1(K375W) Proteins Modulate the Antiapoptotic Activity of Bcl-2 then began to decline in cultures of 32D-Neo, 32D-Raf-1-CAAX, and 32D-M-Raf-1(K375W) cells (data not
If the interaction of Bcl-2 with Raf-1 plays a role in the regulation of apoptosis by Bcl-2, then coexpressing an shown). In addition to MTT assays, the results of these active Raf-1 kinase with Bcl-2 should enhance resisfor exploring the molecular control of apoptosis (Weil et al., 1996) . To determine whether the ability of Raf-1 tance to apoptosis compared with the resistance in cells transfected with Bcl-2 alone. Conversely, the inactive and Bcl-2 to cooperate in the suppression of apoptosis extends beyond the paradigm of IL-3 withdrawal, the Raf-1 mutant should potentially reduce the resistance of Bcl-2-expressing cells to apoptosis, by interfering various 32D.3 transfectants described above were cultured with 1 M staurosporine in the presence of IL-3. with the interaction of Bcl-2 with the endogenous, wildtype Raf-1 protein. To test this hypothesis, a clone of Relative numbers of viable cells were then determined 1 day later by MTT assay. As shown in Figure 5A , approx-32D.3 that had been previously transfected with Bcl-2 by using a hygromycin-resistance marker was stably imately 1.5-fold more 32D.3-Bcl-2 cells survived treatment with staurosporine than did 32D.3-Neo cells (p Ͻ transfected with pcDNA-3 expression plasmids, producing first an active form of the Raf-1 protein consisting 0.01 by unpaired t test). The 32D.3 cells expressing the mitochondria-targeted and constitutively active Raf-1 essentially only of the catalytic domain (Cat) of Raf-1 (⌬2-334) ; second, an inactive K375W mutant Raf-1 protein M-Raf-1 withstood treatment with staurosporine about as well as the 32D.3-Bcl-2 cells (p Ͻ 0.01 for lacking the Ras-binding domain (⌬26-303) ; or third, the pcDNA-3 parental vector as a control (contains the M-Raf-1 versus Neo). In contrast, 32D.3 cells transfected with a plasmid encoding the plasma membrane-tar-G418-resistance gene). It was important to eliminate the Ras-binding domain in the K375W mutant Raf-1 progeted Raf-1-CAAX protein ( Figure 5A ) or untargeted Raf-1(Cat) (data not shown) survived no better than the tein so as to avoid interference with Ras-regulated pathways that are required for cell proliferation (Kolch et al., 32D-Neo control cells. In contrast, 32D.3 cells coexpressing the same Raf-1(Cat) protein with Bcl-2 exhib-1991; Porras et al., 1994; . Unlike the experiments above, mitochondrial targeting seited significantly greater resistance to staurosporine, compared with 32D.3 cells expressing Bcl-2 alone (p Ͻ quences were not included in the active and inactive Raf-1 proteins, thus making the association of these 0.05 by unpaired t test). None of the various 32D.3 transfectants, however, was resistant to staurosporineproteins with mitochondrial membranes dependent on interactions with Bcl-2.
induced cell cycle arrest (data not shown), implying that the enhanced resistance to this kinase inhibitor cannot Immunoblot analysis of the Bcl-2, Bcl-2-Raf-1(Cat), and Bcl-2-Raf-1(K375W) cells using an antiserum spebe explained by reduced import of the drug or accelerated metabolism to inactive products. cific for the human Bcl-2 protein demonstrated essentially equivalent amounts of plasmid-derived human Since Bcl-2 is well known for its ability to inhibit staurosporine-induced apoptosis and because 32D.3 Bcl-2 protein in these cells (see Figure 3A) , the levels of which were comparable to those in some human cells expressing the mitochondria-targeted Raf-1 protein exhibited increased resistance to staurosporinetumor lines that overexpress Bcl-2 (data not shown). Incubation of the same blot with an antiserum directed mediated cell death, it was important to determine whether Raf-1 is a staurosporine-resistant or -sensitive against a peptide corresponding to the C-terminus of Raf-1 demonstrated the presence of the expected ‫53ف‬ kinase. For this purpose, Raf-1 was expressed in Sf9 cells by using a recombinant baculovirus that encoded kDa Raf-1(Cat) and ‫24ف‬ kDa Raf-1(K375W) proteins (see Figure 3A) . a mutant version of Raf-1 (259D) that has constitutively high levels of kinase activity (Morrison et al., 1993 ; Wang When deprived of IL-3, 32D.3 cells coexpressing Bcl-2 and Raf-1(Cat) exhibited prolonged survival compared et al., 1996) . Immunoprecipitates of Raf-1(259D) protein were then prepared from baculovirus-infected Sf9 cells, with cells expressing Bcl-2 alone ( Figure 4B ). In contrast, 32D.3 cells coexpressing Bcl-2 and Raf-1(K375W) had and the ability of this kinase to phosphorylate the substrate protein GST-MEK in the presence or absence of reduced survival compared with cells expressing Bcl-2 alone. The kinetics of cell death in cultures of 32D-various concentrations of staurosporine was tested. As shown in Figure 5B , concentrations of staurosporine as Bcl-2-Raf-1(K375W) cells, for instance, were essentially the same as in the control 32D.3-Neo cells that lacked high as 5 M had no inhibitory effect on Raf-1 kinase activity, and even Ն10 M had only modest effects Bcl-2 ( Figure 4B ), indicating that this dominant inhibitory form of Raf-1 completely abrogated the protective effect (Ͻ30% inhibition). From these studies, therefore, we conclude first that targeting of activated Raf-1 kinase of Bcl-2 on cell survival. Cells transfected with the plasmid encoding the active Raf-1(Cat) protein, without to mitochondria, either by fusion with the TM domain of Mas70p or through its interaction with Bcl-2, promotes Bcl-2, also displayed cell survival characteristics indistinguishable from those of the Neo control cells (Wang resistance to staurosporine-induced apoptosis, and second, that Raf-1 is a staurosporine-resistant kinase. et al., 1994), suggesting that Raf-1 inefficiently participates in the suppression of apoptosis in those cells that contain relatively low levels of endogenous Bcl-2
Raf-1 Regulates the Phosphorylation of Different protein.
Proteins When Targeted to Plasma Membrane versus Mitochondria
Since Bcl-2 can promote association of Raf-1 with mitoRaf-1 Cooperates with Bcl-2 in Suppressing Staurosporine-Induced Apoptosis chondria, whereas Ras induces association of Raf-1 with the plasma membrane, it seems likely that activated The broad-specificity protein kinase inhibitor staurosporine has been shown to induce apoptosis in essenRaf-1 protein would encounter different substrates at these two membrane sites. To explore this possibility, tially all types of cells derived from metazoan species and thus has been used extensively as a general tool the state of phosphorylation of extracellular signal-and the gel mobility of ERK1 and ERK2 was compared. Cells expressing the Raf-1-CAAX protein contained both the unphosphorylated ‫24ف‬ kDa ERK1 and ‫44ف‬ kDa ERK2 proteins as well as the higher molecular weight, phosphorylated forms of ERK1 and ERK2 ( Figure 6A ). In contrast, 32D.3 cells expressing M-Raf-1 and 32D.3 cells coexpressing Bcl-2 and untargeted Raf-1(Cat) contained only the unphosphorylated forms of ERK1 and ERK2. The differences in ERK1 and ERK2 phosphorylation seen in 32D.3 cells expressing the M-Raf-1 and Raf-1-CAAX proteins cannot be attributed to lower levels of the kinase activity in the former, since both the M-Raf-1 and Raf-1-CAAX proteins lacked the N-terminal regulatory region where Ras binds and were already maximally active. These findings thus support the idea that targeting of Raf-1 to different intracellular membrane compartments through its interactions with Ras (plasma membrane) and Bcl-2 (mitochondrial membranes) promotes the interactions of Raf-1 with different substrate proteins.
What then are the substrates of Raf-1 at mitrochondrial membranes? Previously, we observed that while Raf-1 can associate with Bcl-2, it does not normally phosphorylate it . To explore the possibility that Raf-1 might phosphorylate other Bcl-2 family proteins, baculovirus-produced Raf-1 (259D) protein was tested for its ability to phosphorylate in vitro the bacterially produced fusion proteins GST-Bcl-2, GSTBcl-XL, GST-Bcl-Xs, GST-Mcl-1, GST-Bax, GST-Bak, and GST-BAD, making comparisons with the known substrate GST-MEK. Among these various GST fusion proteins, only GST-BAD and GST-MEK were phosphorylated in vitro by Raf-1 ( Figure 6B ).
To determine whether the BAD protein becomes phosphorylated in intact cells when Raf-1 is targeted to mitochondria, 293 cells were transiently cotransfected with a plasmid producing a hemagglutinin (HA) epitopetagged human BAD protein and plasmids producing the various versions of Raf-1 described above: M-Raf-1, BAD protein in intact cells, whereas M-Raf-1(K375W) was examined. The ERK1 and ERK2 proteins become and Raf-1-CAAX did not ( Figure 6D ). phosphorylated in a Ras-dependent manner by MAPK/ ERK kinase (MEK), a direct substrate of Raf-1 whose Discussion enzymatic activity becomes elevated upon stimulation of cells with various growth factors (Kyriakis et al., 1992) .
The findings reported here suggest a novel role for Raf-1 The phosphorylation of ERK1 and ERK2 results in a shift at mitochondrial membranes (and possibly other intrain their mobility upon SDS-polyacrylamide gel electrocellular membranes where Bcl-2 resides) as a blocker of phoresis (PAGE) to slower-migrating species that can apoptotic cell death, as opposed to its more traditionally be detected by immunoblot analysis.
known role as a promoter of cell proliferation and differThe 32D.3 cells expressing the M-Raf-1 and Raf-1-entiation within the context of the Ras signaling pathways at the plasma membrane. Several analogies can CAAX proteins were therefore deprived of IL-3 for 6 hr Figure 6 . Differential Phosphorylation of ERK1, ERK2, and BAD in 32D.3 Cells Expressing Mitochondria-and Plasma Membrane-Targeted Active Raf-1 (A) Phosphorylation of ERK1 and ERK2 in 32D.3-Raf-1-CAAX, 32D.3-M-Raf-1, and other transfectants was examined based on altered migration of the phosphorylated proteins in gels. Stably transfected 32D.3 cells were cultured in the absence of IL-3 for 6 hr, and lysates were prepared (25 g per lane). Data represent SDS-PAGE/immunoblotting using anti-ERK rabbit antiserum. (B) Raf-1(259D) was tested for ability to phosphorylate various GST fusion proteins in vitro as described for Figure 5B . Anti-Raf antiserum/protein A complexes lacking Raf-1(259D) protein were used as a control (CNTL). (C) 293 cells were transiently transfected with 20 g of pcDNA3-HA-BAD and 20 g of pcDNA-3 plasmid (Neo) (lanes 1 and 5) or pcDNA-3 encoding Raf-1-CAAX (lanes 2 and 6), M-Raf-1(K375W) (lanes 3 and 7) , or M-Raf-1 (lanes 4 and 8). After 2 days, the cells were cultured in 0.5% serum for 6 hr, and cell lysates (50 g of total protein) were incubated with 1 U of alkaline phosphatase at 37ЊC for 4 hr in the presence (plus) or absence (minus) of phosphatase inhibitors prior to SDS-PAGE/immunoblot analysis using anti-HA monoclonal antibody and ECL-based detection. Reprobing the same blot with anti-Raf antibody confirmed production of comparable amounts of the M-Raf-1, M-Raf-1(K375W), and Raf-1-CAAX proteins (data not shown). (D) 293 cells were transiently cotransfected with 20 g of pFLAG-CMV2-BAD and 20 g M-Raf-1, M-Raf-1(K375W), or Raf-1-CAAX-producing plasmids and labeled with 32 PO4 2 days later. FLAG-BAD protein was immunoprecipitated with anti-FLAG antibody, subjected to SDS-PAGE, and transferred to nitrocellulose filters, followed by exposure to X-ray film to detect 32 P-labeled FLAG-BAD (top). The blot was subsequently probed with anti-FLAG antibody and developed by ECL, demonstrating comparable amounts of FLAG-BAD protein in all samples (bottom).
be drawn between the mechanisms by which p21 ras and to the N-terminal regulatory domain of Raf-1 (Zhang et al., 1993), Bcl-2 interacts with the C-terminal catalytic Bcl-2 target Raf-1 to membranes. For example, because the Bcl-2 protein resides in the outer mitochondrial domain . Indeed, it was this difference in the locations on the Raf-1 protein where Bcl-2 and membrane, with its C-terminal TM domain integrated into membranes and the bulk of the protein oriented Ras bind that allowed us to explore the effects of constitutively active and kinase-inactive Raf-1 mutants (which toward the cytosol Lithgow et al., 1994) , we presume that the Bcl-2-Raf-1 interaction lacked the Ras-binding domain) on the Bcl-2 pathway for suppression of apoptosis, in the absence of interferbrings Raf-1 to the surface of the outer mitochondrial membrane. Similarly, p21 ras family proteins orient their ing effects on p21 ras function. Overexpression of Bcl-2 can inhibit cell proliferation C-termini toward the plasma membrane because of covalent attachment of lipids at the CAAX box motif and in some situations, perhaps by slowing the rate of progression through G 1 -S phase (Pietenpol et al., 1994 ; can bring Raf-1 from the cytosol to the plasma membrane through Ras-Raf-1 protein-protein interactions Borner, 1996; Mazel et al., 1996) . Given the ability of p21 ras and Bcl-2 to target Raf-1 to different membrane (Hall, 1994) . Furthermore, just as targeting of Raf-1 to plasma membranes by fusing the CAAX box motif onto compartments, with Raf-1 presumably participating in pathways involved in mitogenesis at the plasma memRaf-1 has been shown to allow for Ras-independent activation of Raf-1 and phosphorylation of the Raf-1 brane and other pathways related to cell survival control at mitochondrial membranes, it is tempting to speculate substrate MEK (Stokoe et al., 1994; Leevers et al., 1994) , fusing activated Raf-1 with the TM domain Mas70p althat this phenomenon of growth suppression by Bcl-2 may reflect a competition between Ras and Bcl-2 family lowed for Bcl-2-independent inhibition of apoptosis by Raf-1. These similarities between Ras and Bcl-2 with proteins for limiting amounts of Raf-1. Though Ras can target Raf-1 to plasma membranes, regards to interactions with Raf-1 emphasize the importance of protein-protein interactions for the intracellular resulting in activation of the kinase, it remains controversial whether this protein-protein interaction is sufficient targeting of kinases to sites of biological importance (Faux and Scott, 1996) . Presumably, it is through these to activate Raf-1. Indeed, the bulk of evidence supports the idea that other proteins, including other protein kiprotein-protein interactions that specificity is achieved in terms of targeting kinases to appropriate substrates, nases, are required for Ras-mediated activation of Raf-1 (Jelinek et al., 1996) . In the experiments presented here, a concept supported by the differential phosphorylation of ERK1, ERK2, and BAD shown here in 32D.3 cells we have bypassed the need for kinase activation by deleting the negative regulatory domain of Raf-1. The expressing mitochondrial (M-Raf-1) and plasma (Raf-1-CAAX) membrane-targeted versions of active Raf-1.
question then is how is the kinase activity of Raf-1 normally turned on when brought into the vicinity of the An interesting difference in the ways that p21 ras proteins and Bcl-2 interact with Raf-1 is that while Ras binds mitochondrial or other intracellular membranes where Bcl-2 resides? A potential answer has come recently cell death (Han et al., 1993; Lu et al., 1994; Tsuda et al. , from the finding that another Bcl-2-associated protein, 1993) . Moreover, the recently reported structure of the BAG-1, can bind to and activate Raf-1 through an unBcl-X L protein suggests that Bcl-2 family proteins may known mechanism . Like Bcl-2, the have intrinsic functions as pore-forming proteins (Muchcatalytic domain of Raf-1 is sufficient for the interaction more et al., 1996) , irrespective of their interactions with with BAG-1. Also, binding of BAG-1 to Bcl-2 is depenother proteins. Thus, it seems unlikely that the Raf-1-dent on the BH4 domain, similar to the interaction of Bcl-2 interaction is absolutely required for suppression Raf-1 with Bcl-2. Thus, a preformed BAG-1-Raf-1 comof apoptotic cell death. Nevertheless, the finding that plex may bind to the BH4 domain of Bcl-2, thus bringing a dominant-inhibitory mutant of Raf-1 lacking kinase Raf-1 to mitochondrial membranes associated with an activity completely abrogated the survival-promoting efactivating protein, BAG-1. Alternatively, since Bcl-2 can fects of Bcl-2 in 32D.3 cells argues that Raf-1 can at form dimers or larger oligomers least be a potent modulator of Bcl-2 function in some et al., 1994), it is possible that Raf-1-BAG-1 complexes types of cells. The interaction of Raf-1 with Bcl-2, thereassemble on Bcl-2 dimers/oligomers via interactions fore, may provide a target for future attempts at modulatwith BH4 domains on different Bcl-2 protein molecules.
ing Bcl-2 protein activity for therapeutic benefit. Clarifying the structural details of how these protein complexes form and the precise mechanisms responsi- Bcl-XS can be attributed to the capacity of the former All other plasmids have been described to dimerize with BAD and the inability of latter to do so et al., 1995) . (Sedlak et al., 1995) , though other explanations are also possible.
Cell Transfections
The 32D.3 cells were maintained in IL-3-containing medium, and 20
While the Bcl-2-Raf-1 interaction defines a novel regug of plasmid DNAs was introduced by electroporation as described latory event in the control of apoptosis, it is unclear . The 293 cells were transfected by a calcium whether it is essential for the function of Bcl-2 as a phosphate method . suppressor of cell death. The observation that Raf-1 is a staurosporine-resistant kinase that can collaborate
Coimmunoprecipitation Assay
with Bcl-2 in the inhibition of staurosporine-induced
Infections of Sf9 cells with recombinant baculoviruses and coimmunoprecipitation assays were performed as described (Wang et al., apoptosis is at least consistent with the idea that the 1994, 1995, 1996) with antisera specific for Raf-1, Bcl-2, Bcl-X, or Bcl-2-Raf-1 interaction may be critical, inasmuch as were infected with GST-Raf-1 or GST-Raf-1(⌬CR3) recombinant baculoviruses (MOI ‫,)01ف‬ and lysates were prepared gest an essential role for Raf in preventing programmed in 4 ml of Triton X-100 lysis buffer (150 mM NaCl, 10 mM Tris [pH M, or 20 M staurosporine. Phosphorylation of GST-MEK was analyzed by SDS-PAGE/autoradiography, and the results were 7.4], 5 mM EDTA [pH 8.0], 1% Triton X-100) containing 1 mM PMSF, 5 g/ml leupeptin, and 5 g/ml aprotinin. Lysates were mixed with quantified with a ␤-scanner (Bio-Rad, Incorporated). Alternatively, 1 g of GST-BAD or other GST fusion proteins was added, instead 100 l of glutathione-Sepharose for 3 hr at 4ЊC. The beads were washed three times with 1 ml of NP-40 lysis buffer supplemented of GST-MEK. with protease inhibitors and resuspended in 0.5 ml of the same solution. GST-loaded beads (5 g protein on ‫02ف‬ l) were incubated
Immunoblot and Immunoprecipitation Assays with 10 l of reticulocyte lysates (TNT-lysates; Promega, Incorpo-32D.3 cells (5 ϫ 10 6 ) were washed three times with Iscove's modified rated) containing in vitro translated [
35 S]methionine-labeled Bcl-2, Dulbecco's medium (IMDM) and cultured in 10 ml IMDM containing Bcl-2(⌬BH4), Bcl-X S, or Bax for 3 hr at 4ЊC. After extensive washing 10% FCS without IL-3 for 6 hr. Cells were lysed in Triton X-100 lysis in NP-40 lysis buffer, beads were boiled in Laemmli buffer and buffer containing protease inhibitors and phosphatase inhibitors (10 eluted proteins analyzed by SDS-PAGE (12% gels) and detected mM sodium ␤-glycerophosphate [pH 7.4], 1 mM Na 3VO4, 5 mM NaF, by fluorography.
2 mM Na 4P2O7, 50 mM 4-nitrophenyl phosphate, and 1 M microcystin). The resulting lysates (25 g per lane) were subjected to 10% Yeast Two-Hybrid Assay SDS-PAGE immunoblot analysis (10% gels with 2% SDS) using 0.1 The cDNA fragments encoding Raf-1, Bcl-2(1-218) without its TM g/ml anti-ERK rabbit antiserum (Santa Cruz Biotech, Incorporated), domain, Bcl-2(1-218)(⌬BH4), Bcl-2(1-81), Bcl-2(1-81)(⌬BH4), Bclfollowed by 0.3 g/ml horseradish peroxidase-goat anti-rabbit (Bio-2(83-218), and Bax(1-171) without its TM were subcloned from Rad) and detection by an enhanced chemiluminescence (ECL) syspEG202 (Hanada et al., 1995) into the two-hybrid vector pGilda (gift tem (Amersham). of E. Golemis and D. Buckholtz), which produces fusion proteins After transfection (2 days), 293 cells were cultured in medium with a LexA DNA-binding domain at the N-terminus under the control with 0.5% serum for 6 hr, and cell lysates (50 g of total protein) of a Gal1 promoter (Estojak et al., 1995) . EGY191 strain yeast was were incubated with 1 U of alkaline phosphatase at 37ЊC for 4 hr in cotransformed with various pGilda expression plasmids in combinathe presence or absence of phosphatase inhibitors prior to SDStion with various pJG4-5 plasmids, which produce B42 trans-activa-PAGE immunoblot analysis using anti-HA monoclonal antibody and tion domain fusion proteins as described ; Hanada ECL-based detection. Alternatively, the transfected cells were laet al., 1995). Filter assays were performed for ␤-galactosidase meabeled with 32 PO4 for 10 hr in phosphate-free Dulbecco's modified surements, by using cells plated on either galactose-or glucoseEagle's medium containing 0.5% dialyzed serum and 0.5 mCi/ml containing MM medium supplemented with 20 g/ml leucine. Colori-32 PO4. FLAG-BAD protein was immunoprecipitated with the M2 antimetric results were photographed after 2.5 hr.
body (Kodak, Incorporated).
